atropine has been researched along with atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)- in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) | Trials (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) | Recent Studies (post-2010) (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 60 | 1 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianciotti, LG; Corbo, NS; RodrÃguez, MR; Sabbatini, ME; Vatta, MS | 1 |
1 other study(ies) available for atropine and atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-
Article | Year |
---|---|
C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Topics: Animals; Atrial Natriuretic Factor; Atropine; Brain; Cyclic GMP; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pancreas; Parasympatholytics; Peptide Fragments; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Secretin; Sincalide; Thionucleotides; Time Factors; Vagotomy; Vagus Nerve; Vasoactive Intestinal Peptide | 2005 |